From: Concurrent validity of provisional remission criteria for gout: a dual-energy CT study
Domain | N (%)with DECT urate crystal deposition for participants fulfilling individual domain/provisional criteria | N (%) with DECT urate crystal deposition for participants not fulfilling individual domain/provisional criteria | Odds ratio (95% CI) | P |
---|---|---|---|---|
Serum urate (< 0.36 mmol/L) | 43 (56) n = 77 | 62 (83) n = 75 | 0.27 (0.13–0.56) | < 0.001 |
Tophus (absence) | 67 (64) n = 104 | 38 (79) n = 48 | 0.48 (0.22–1.03) | 0.07 |
Flares (none in the last 12 months) | 44 (63) n = 70 | 61 (74) n = 82 | 0.58 (0.29–1.15) | 0.13 |
Pain (due to gout, < 2) | 70 (67) n = 104 | 35 (73) n = 48 | 0.76 (0.37–1.65) | 0.49 |
Patient global assessment of gout activity (< 2) | 52 (62) n = 84 | 53 (78) n = 68 | 0.46 (0.22–0.94) | 0.03 |
Provisional remission criteria (all five domains) | 10 (44) n = 23 | 95 (74) n = 129 | 0.28 (0.11–0.65) | 0.004 |